Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Aicardi's Diseases of the Nervous System in Childhood
Congenital or early-onset disorders of the nervous system have a profound and lifelong impact on the lives of children and their families. Diseases of the Nervous System in Childhood provides up-to-date information on the full range of these neurological disorders, from fetal and neonatal neurology to adolescence. Movement disorders, epilepsies and seizure disorders, metabolic diseases, auditory and visual disorders, and genetic anomalies are among the many topics covered in this text. Extensive reference lists at the end of each chapter guide the clinician to further relevant reading. This fourth edition retains the patient-focussed, clinical approach of its predecessors. The international team of editors and contributors has honoured the request of the late Jean Aicardi, that his book remain ‘resolutely clinical’, which distinguishes Diseases of the Nervous System in Childhood from other texts in the field. This edition: Is completely revised and updated Includes latest developments in genetic advances Contains new chapters on basal ganglia diseases and psychogenic disorders Has an easy-to-use one volume format with full-colour illustrations
Pediatric Epilepsy
Market: Neurologists and pediatricians Diagnostic and treatment algorithms appear throughout Includes sections on comorbidities and monotherapy vs. polytherapy
Paediatric Movement Disorders
Paediatric Movement Disorders is an exciting field of Child Neurology. In recent years, an important amount of new knowledge has accumulated at an increasing place, both on basic and on clinical aspects of Child Neurology. Highly qualified experts of the corresponding fields wrote chapters of this book that represent the “state-of-the-art” in this excited field of Chiold Neurology and will prove to be a useful tool to both clinicians and scientists.
From First Unprovoked Seizure to Newly Diagnosted Epilepsy
This new edition of the book series dedicated to “Progress in Epileptic Disorders” is the result of a recently held unique gathering of international experts that debated on the prognostic and therapeutic issues raised by the management of first unprovoked seizures and of newly diagnosed epilepsy. Current knowledge on natural evolution of a first seizure, the role of co-morbid conditions, the impact of immediate versus delayed treatment and recent guidelines are thoroughly addressed. The new ideas and suggestions that emerge from this book offer challenging perspectives for both patient care and clinical as well as fundamental research. The first section of the book includes an up to dat...
Cognitive Dysfunction in Children with Temporal Lobe Epilepsy
Much has been written about the cognitive function of children with epilepsy but despite there being extensive study of the neuropsychological status of adults with intractable temporal lobe epilepsy, it has been more limited in children. Although cognitive development in children is influenced by similar factors to adults, the role of early damage, modification of cerebral organisation and interruption of the learning process are also likely to be important. Devoted to cognitive function and dysfunction in children with temporal lobe epilepsy, this book highlights those domains that demand further research and those for which immediate established techniques for a better global care can be undertaken.
Cognitive Dysfunction in Children with Temporal Lobe Epilepsy
This book is devoted to cognitive function and dysfunction in children with temporal epilepsy. It also highlights those domains that need further research and those for which immediate established techniques for a better global care can be undertaken. With Contributions from highly qualified experts from around the world, the book extensively reviews available data from both clinical and fundamental research studies.
Drug-Resistant Epilepsies
Over 12 million people with epilepsy have seizures that cannot be controlled by antiepileptic drugs. The term "drug-resistance" is abundantly used in the epilepsy literature but the definitions proposed differ considerably. It is used indifferently in a number of different settings: as a criterion for selection of patients eligible for new antiepileptic drug trials, for the selection of surgical candidates, for the design of epidemiological studies, for the design of studies on quality of life, for the definition of the epileptic encephalopathies (in comparison to more benign epilepsy syndromes), to mention but a few. As a result, available studies are usually not comparable and referral to epilepsy specialists is unacceptably delayed. The volume includes several focused chapters on all issues relating to drug-resistance and offers the basis for a consensus on a clinically meaningful core definition.
Generalized Seizures: From Clinical Phenomenology to Underlying Systems and Networks
The present book is the fruit of a workshop, designed as a discussion forum, with the participation of experts from all over the world, to extensively review clinical, neurophysiological and fundamental research available data in order to generate new axes for research, clinical practice and care. The first section traces back to the definitions and concepts underlying the terms “generalized seizures and epilepsies”. Section II reviews human and animal data suggesting that the brainstem network plays an important role for tonic seizures generation. The third and fourth sections analyze recent knowledge on cortico-thalamic and basal ganglia networks in absence and myoclonic seizures, both in animal models and in humans. The fifth section compares the phenomenology of “Primary versus Secondary Tonico-clonic seizures”, including animal data, clinical expression in humans and genetics. Section VI goes back to the discussion “Cortical” versus “Centrencephalic” theories. The last two chapters thoroughly review the clinical applications of current knowledge, in terms of pharmacological approach and clinical care.
Drug-Resistant Epilepsies
More than 12 million people with epilepsy have seizures that cannot be controlled by antiepileptic drugs. The term "drug-resistance" is abundantly used in the epilepsy literature but the definitions proposed differ considerably. It is used indifferently in a number of different settings: as a criterion for selection of patients eligible for new antiepileptic drug trials, for the selection of surgical candidates, for the design of epidemiological studies, for the design of studies on quality of life, for the definition of the epileptic encephalopathies (in comparison to more benign epilepsy syndromes), to mention but a few. As a result, available studies are usually not comparable and referral to epilepsy specialists is unacceptably delayed. The present volume of Progress in Epileptic Disorders includes several focused chapters on all issues relating to drug-resistance and offers the basis for a consensus on a clinically meaningful core definition.
